Combining P-Tau217 Blood Tests with APOE4 Genotyping Forecasts Alzheimer’s Symptom Onset, Study Finds
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
A blood test and genetic analysis can anticipate the onset of Alzheimer's disease symptoms up to six years agoCercetators at Columbia University in the United States have identified a method that allows estimation of the time of the first Alzheimer's disease symptoms to appear, several years before ...More ...
Combining p-tau217 Blood Tests with APOE4 Genotyping Forecasts Alzheimer’s Symptom Onset, Study Finds
A Columbia University study finds that combining plasma p-tau217 blood tests with APOE4 genotyping can predict Alzheimer’s symptom onset within three to four years in high-risk, asymptomatic individuals.
AGI - By combining the concentration in the blood of the p-tau217 protein with the presence of the genetic variant APOE4 it is possible to estimate more accurately when the first symptoms of Alzheimer's may appear in people still without cognitive disorders. This is what emerges from an analysis conducted by Richard Mayeux and colleagues of Columbia University about 8,500 participants from different ethnic groups and published in The Lancet Neur…
New Blood and Gene Test Combo Can Predict Alzheimer's Symptoms Years Before They Appear, Study Finds
A Columbia University study found that combining the p-tau217 blood biomarker with APOE4 genetic testing may estimate when Alzheimer's symptoms will emerge in symptom-free people.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
